The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IIb study of selinexor in combination with carfilzomib, daratumumab, or pomalidomide in patients with multiple myeloma relapsing on current therapy.
 
Noa Biran
Honoraria - Abbvie; Bristol-Myers Squibb; Janssen Oncology; Karyopharm Therapeutics; Pfizer
Consulting or Advisory Role - Pfizer; Sanofi/Aventis
Speakers' Bureau - Bristol-Myers Squibb; Janssen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst)
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis; Sorrento Therapeutics
Consulting or Advisory Role - Cellectar; Janssen
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
 
Harsh V. Parmar
Consulting or Advisory Role - Cellectar; Sanofi
 
Pooja Phull
No Relationships to Disclose
 
Kimberley Doucette
Consulting or Advisory Role - Cellectar
 
Rena Feinman
Honoraria - GlaxoSmithKline (I); Takeda (I)
Consulting or Advisory Role - BMS (I); Celularity (I); Janssen Oncology (I); Neximmune (I); Pepticom (I)
 
Joshua Zenreich
No Relationships to Disclose
 
Palka Anand
No Relationships to Disclose
 
Kristin Ivanovski
No Relationships to Disclose
 
Monique Pace
No Relationships to Disclose
 
Genevieve Breeze
No Relationships to Disclose
 
Rania Amer
No Relationships to Disclose
 
Lisa Biamonte
No Relationships to Disclose
 
Adolfo Aleman
No Relationships to Disclose
 
Rashmi Unawane
No Relationships to Disclose
 
Elizabeth Pendergrass
Research Funding - Lombardi Comprehensive Cancer Center (Inst)
 
Alexandra Della Pia
No Relationships to Disclose
 
Susan Kumka
No Relationships to Disclose
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Honoraria - GlaxoSmithKline; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celularity; Janssen Oncology; Merck; Neximmune; Pepticom